Medical device recalls Moderate risk

Oxoid Agglutinating Sera recalled over Salmonella risk

Recall date
March 25, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Remel Europe Ltd. recalls Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Recall number
Z-1923-2026
FDA classification
Class II
Brand / firm
Remel Europe Ltd.
Sold / distributed
Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.

Why it was recalled

Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Oxoid Agglutinating Sera, Salmonella 9-0 R30957301

Get recall alerts

Free email alert whenever Remel Europe Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Remel Europe Ltd.